Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonia Kirschner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer TherapyTonia Kirschner, Matthias P Müller, Daniel Rauh
Scientific Reports|November 1, 2025
Targeting KRAS<sup>G13C</sup> with cyclic linker based inhibitors to explore warhead orientationTonia Kirschner, João Rodriguez, Emerson Gonçalves Moreira, et al.
Elife|March 27, 2023
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitorsLisa Goebel, Tonia Kirschner, Sandra Koska, et al.
Nature Communications|September 7, 2021
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsLena Quambusch, Laura Depta, Ina Landel, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer TherapyTonia Kirschner, Matthias P Müller, Daniel Rauh
Scientific Reports|November 1, 2025
Targeting KRAS<sup>G13C</sup> with cyclic linker based inhibitors to explore warhead orientationTonia Kirschner, João Rodriguez, Emerson Gonçalves Moreira, et al.
Elife|March 27, 2023
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitorsLisa Goebel, Tonia Kirschner, Sandra Koska, et al.
Nature Communications|September 7, 2021
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsLena Quambusch, Laura Depta, Ina Landel, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Pageof 1